Pioneer Pharma starts bookbuilding for $215m HK IPO
Shanghai-based China Pioneer Pharma Holdings started gathering orders for its HK$1.67bn ($215m) IPO on October 22 as it looks to list on the Hong Kong Stock Exchange by early November.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts